331A — Medix Cashflow Statement
0.000.00%
- ¥4bn
- ¥1bn
- ¥4bn
- 74
- 81
- 37
- 74
Annual cashflow statement for Medix, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS |
Standards: | JAS | JAS |
Status: | Final | Final |
Net Income/Starting Line | 637 | 788 |
Depreciation | ||
Non-Cash Items | 147 | -30.6 |
Unusual Items | ||
Other Non-Cash Items | ||
Changes in Working Capital | -297 | -123 |
Change in Accounts Receivable | ||
Change in Prepaid Expenses | ||
Change in Accounts Payable | ||
Change in Accrued Expenses | ||
Change in Other Liabilities | ||
Other Operating Cash Flow | ||
Cash from Operating Activities | 558 | 676 |
Capital Expenditures | -44.8 | -44.1 |
Purchase of Fixed Assets | ||
Purchase / Acquisition of Intangibles | ||
Other Investing Cash Flow Items | 73.4 | 52.6 |
Sale/Maturity of Investment | ||
Purchase of Investments | ||
Other Investing Cash Flow | ||
Cash from Investing Activities | 28.7 | 8.51 |
Financing Cash Flow Items | -28 | -45.5 |
Other Financing Cash Flow | ||
Net Issuance / Retirement of Stock | ||
Net Issuance / Retirement of Debt | ||
Cash from Financing Activities | -0.544 | -218 |
Beginning Cash Balance | ||
Ending Cash Balance | ||
Net Change in Cash | 586 | 467 |